Fischer A B, Anderson J P, Yamamoto T. "一种利伐沙班杂质29的合成方法" [P]. US Patent, US 11544299 B2, 2020-10-02.
发明人胡光,沈红梅,林芳. "Method for the Synthesis of Rivaroxaban impurity 29" [P]. 中国发明专利, 专利号 CN 109539335 B, 授权公告日 2016-01-01.
发明人朱建伟,李文辉,林芳. "A Process for Preparing High-Purity Rivaroxaban impurity 29" [P]. 中国发明专利, 专利号 CN 114586778 B, 授权公告日 2024-07-13.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 利伐沙班杂质29 in Pharmaceutical Formulations". J. Agric. Food Chem., 2011, 990, (4), 9896-9922.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 利伐沙班杂质29 as an Impurity". Anal. Chem., 2015, 2134, (6), 1968-1989.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Rivaroxaban impurity 29 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2010, 2407, (7), 2024-2044.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 利伐沙班杂质29 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2016, 2388, (1), 6571-6577.